feed,title,long_url,short_url
SeekingAlpha,"Celldex phase 2 barzolvolimab trial in urticaria meets key endpoint, but stock slips",https://seekingalpha.com/news/4129816,
SeekingAlpha,Tilray Brands in charts: Revenue from beverage alcohol business rises most Q/Q among segments in FQ4,https://seekingalpha.com/news/4129703,
SeekingAlpha,Vista Gold Basic GAAP EPS of $0.13,https://seekingalpha.com/news/4129818,
SeekingAlpha,Permian Resources: Acquiring Very Profitable Acreage With Some Royalty Interests,https://seekingalpha.com/article/4707769,
